Models of intervention and care for psychostimulant users, 2nd edition - monograph series no. 51

Chapter 8: Pharmacological interventions

Page last updated: April 2004

James Shearera and Linda Gowingb

a National Drug and Alcohol Research Centre, New South Wales
b Drug and Alcohol Services Council, South Australia

Key points:
  • With the exception of pharmacotherapies targeted towards accurately and appropriately diagnosed comorbid conditions such as affective disorders, psychotic disorders, attention deficit disorders and opioid dependence, no pharmacotherapy has been shown to be effective in the management of psychostimulant disorders.

  • The inherent risks of pharmacotherapy suggest that the use of pharmacotherapeutic agents should be limited to users who experience the greatest burden of psychostimulant-related harms.